Cargando…
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis
RATIONALE & OBJECTIVE: Recent studies showed that antibody titers after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the dialysis population are diminished as compared with the general population, suggesting the possible value of a third booster dose. We ch...
Autores principales: | Bensouna, Ilias, Caudwell, Valérie, Kubab, Sabah, Acquaviva, Sandra, Pardon, Agathe, Vittoz, Nathalie, Bozman, Dogan-Firat, Hanafi, Latifa, Faucon, Anne-Laure, Housset, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425695/ https://www.ncbi.nlm.nih.gov/pubmed/34508833 http://dx.doi.org/10.1053/j.ajkd.2021.08.005 |
Ejemplares similares
-
Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
por: Housset, Pierre, et al.
Publicado: (2022) -
Humoral response after a fourth “booster” dose of a Coronavirus disease 2019 vaccine following a 3-dose regimen of mRNA-based vaccination in dialysis patients
por: Housset, Pierre, et al.
Publicado: (2022) -
Réponse immunitaire vis-à-vis du vaccin BNT162b2 chez les patients hémodialysés et en dialyse péritonéale
por: Bensouna, I., et al.
Publicado: (2021) -
Hyalinose segmentaire et focale post-vaccination anti-SARS-CoV-2 : une association fortuite ?
por: Faucon, A.-L., et al.
Publicado: (2021) -
Aggravation d’une maladie rénale chronique : la COVID-19, complice ou coupable ?
por: Housset, P., et al.
Publicado: (2021)